Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Wall Street Analysts Believe Epam (EPAM) Could Rally 26.37%: Here's is How to Trade
Wall Street Analysts Believe Epam (EPAM) Could Rally 26.37%: Here's is How to Trade

Epam (EPAM) closed the last trading session at $169.46, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?
Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?

Shares of Aligos Therapeutics, Inc. (ALGS) have gained 47.5% over the past four weeks to close the last trading session at $11.34, but there could still be a solid upside left in the stock if

Wall Street Analysts Predict a 26.76% Upside in Ategrity Specialty Insurance Company Holdings (ASIC): Here's  What You Should KnowPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Wall Street Analysts Predict a 26.76% Upside in Ategrity Specialty Insurance Company Holdings (ASIC): Here's What You Should Know

Shares of Ategrity Specialty Insurance Company Holdings (ASIC) have gained 11.6% over the past four weeks to close the last trading session at $21.3, but there could still be a solid upside left in

Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High?

Phathom Pharmaceuticals, Inc. (PHAT) closed the last trading session at $12.34, gaining 26.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade

DiaMedica Therapeutics, Inc. (DMAC) closed the last trading session at $6.14, gaining 31.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Predict a 34.02% Upside in Salesforce.com (CRM): Here's  What You Should Know
Wall Street Analysts Predict a 34.02% Upside in Salesforce.com (CRM): Here's What You Should Know

Shares of Salesforce.com (CRM) have gained 4.3% over the past four weeks to close the last trading session at $250.76, but there could still be a solid upside left in the stock if short-term price

Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?

Werewolf Therapeutics, Inc. (HOWL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, HOWL's 50-day simple moving average

Should You Buy Clean Energy Fuels (CLNE) After Golden Cross?
Should You Buy Clean Energy Fuels (CLNE) After Golden Cross?

Clean Energy Fuels Corp. (CLNE) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CLNE's 50-day simple moving average broke out

Brixmor Property (BRX) Just Flashed Golden Cross Signal: Do You Buy?
Brixmor Property (BRX) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Brixmor Property Group Inc. (BRX) is looking like an interesting pick, as it just reached a key level of support. BRX's 50-day simple moving average crossed above its

TransAct Technologies Incorporated (TACT)'s Technical Outlook is Bright After Key Golden Cross
TransAct Technologies Incorporated (TACT)'s Technical Outlook is Bright After Key Golden Cross

From a technical perspective, TransAct Technologies Incorporated (TACT) is looking like an interesting pick, as it just reached a key level of support. TACT's 50-day simple moving average crossed

Should You Buy EuroDry (EDRY) After Golden Cross?
Should You Buy EuroDry (EDRY) After Golden Cross?

From a technical perspective, EuroDry (EDRY) is looking like an interesting pick, as it just reached a key level of support. EDRY's 50-day simple moving average crossed above its 200-day simple

Astria Therapeutics, Inc. (ATXS) Now Trades Above Golden Cross: Time to Buy?
Astria Therapeutics, Inc. (ATXS) Now Trades Above Golden Cross: Time to Buy?

From a technical perspective, Astria Therapeutics, Inc. (ATXS) is looking like an interesting pick, as it just reached a key level of support. ATXS's 50-day simple moving average crossed above its

Domino's Pizza (DPZ)'s Technical Outlook is Bright After Key Golden Cross
Domino's Pizza (DPZ)'s Technical Outlook is Bright After Key Golden Cross

Domino's Pizza Inc (DPZ) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, DPZ's 50-day simple moving average broke out above its

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Twilio (TWLO) is a Strong Momentum Stock
Here's Why Twilio (TWLO) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Humana (HUM) is a Top-Ranked Momentum Stock: Should You Buy?
Humana (HUM) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Here's Why Exelixis (EXEL) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Here's Why Brinker International (EAT) is a Strong Momentum Stock
Here's Why Brinker International (EAT) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Carvana (CVNA) is a Top Momentum Stock for the Long-Term
Why Carvana (CVNA) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Allegheny Technologies (ATI) is a Top Momentum Stock for the Long-Term
Why Allegheny Technologies (ATI) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Why Vertiv Holdings Co. (VRT) is a Top Growth Stock for the Long-Term
Why Vertiv Holdings Co. (VRT) is a Top Growth Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different